View of Formulation Development and In-Vitro/In-Vivo Evaluation of Dual-Drug Lipid Nanoparticle Systems for Synergistic Amelioration of Cardiac Pathology in Type 2 Diabetes Mellitus

Return to Article Details Formulation Development and In-Vitro/In-Vivo Evaluation of Dual-Drug Lipid Nanoparticle Systems for Synergistic Amelioration of Cardiac Pathology in Type 2 Diabetes Mellitus Download Download PDF